BEACON THERAPEUTICS
Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.
BEACON THERAPEUTICS
Industry:
Health Care Therapeutics
Founded:
2023-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.beacontx.com
Total Employee:
51+
Status:
Active
Contact:
+1 386 462 2204
Email Addresses:
[email protected]
Total Funding:
290.14 M USD
Technology used in webpage:
Google Maps ReCAPTCHA Google Google Cloud Contact Form 7
Similar Organizations
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Atsena Therapeutics
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Linnaeus Therapeutics
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Nanoscope Therapeutics
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Remedium Bio
Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Ring Therapeutics
Ring Therapeutics company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy.
Current Advisors List
Current Employees Featured
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Series B - Beacon Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Beacon Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series B - Beacon Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series B - Beacon Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Beacon Therapeutics
University of Oxford
University of Oxford investment in Series B - Beacon Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Beacon Therapeutics
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Beacon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2024-07-24 | Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer |
Official Site Inspections
http://www.beacontx.com Semrush global rank: 3.11 M Semrush visits lastest month: 4.91 K
- Host name: 104.21.30.7
- IP address: 104.21.30.7
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Beacon Therapeutics"
About us - Beacon Therapeutics
Beacon Therapeutics: Pioneering ocular gene therapy to restore vision. Transforming lives through innovative science. Learn more about our groundbreaking approach.See details»
Beacon Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 386 462 2204 Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.See details»
Beacon Therapeutics - LinkedIn
Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in โฆSee details»
Careers - Beacon Therapeutics
If youโre passionate about gene therapy and its ability to enhance the lives of patients, then Beacon is a great team to join. Weโre a diverse, multi-national team of talented people all working together at our sites in the US and the UK, or as โฆSee details»
Beacon Therapeutics - Overview, News & Similar companies
Jul 24, 2024 View Beacon Therapeutics (www.beacontx.com) location in Florida, United States , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Beacon Therapeutics - Company Profile & Staff Directory
Discover Beacon Therapeutics company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get โฆSee details»
Beacon Therapeutics: Employee Directory | ZoomInfo.com
Beacon Therapeutics Contact Info: Phone number: (386) 462-2204 Website: www.beacontx.com What does Beacon Therapeutics do? Beacon Therapeutics is an ophthalmic gene therapy โฆSee details»
Beacon Therapeutics - Work in biotech
Beacon Therapeutics was launched in 2023 by Syncona as a gene therapy biotech company whose purpose is to improve or restore vision in patients with various retinal diseases that โฆSee details»
Beacon Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Beacon Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 2 news, Technology Platform:AAV based gene therapy, Drug:Dry Age-related Macular โฆSee details»
Beacon Therapeutics (USA), Inc. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 Contact: [email protected] Media: [email protected] About Beacon Therapeutics Beacon Therapeutics is an ophthalmic gene therapy company founded โฆSee details»
Beacon Therapeutics - Oxford Science Enterprises
Www.beacontx.com. Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to restore and improve the vision of patients with a range of prevalent and rare retinal โฆSee details»
Beacon Therapeutics - VentureRadar
Similar Companies: GenSight Biologics France Publicly Traded GenSight Biologics is a clinical-stage gene therapy company currently focused on discovering, developing and โฆSee details»
Beacon Pharmaceuticals Plc (Beacon Pharmaceuticals Plc) - ่ฏ็ฉ็ฎก โฆ
Contacts:Beacon Therapeutics:David Fellows, CEOEmail: [email protected] Consilium Strategic Communications:Alex Harrison, Ashley TappEmail: [email protected] โฆSee details»
Beacon Therapeutics - ARVO 2025
One Kendall Square 1400W, Suite14102 Cambridge, MA 02139 ... Organization Member ListSee details»
Beacon Therapeutics Company Information - Funding, Investors, โฆ
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Beacon Therapeutics Announces Positive 12-Month Data from โฆ
Feb 8, 2024 [email protected]. Media: [email protected]. About Beacon Therapeutics. Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 โฆSee details»
Beacon Therapeutics Raises $170 Million in Series B Funding to โฆ
Jul 3, 2024 [email protected]. Media: [email protected]. Related news: All news. Beacon Therapeutics Launch. 12 Jun 2023. Subretinal Gene Therapy Drug laru-zova โฆSee details»
Texas border town wins $13M grant for environment work - The โฆ
1 day ago Presidio, northwest of Big Bend National Park, will get dedicated green spaces along bike lanes and pedestrian streets, plant thousands of native trees and establish a high-school โฆSee details»
Beacon Therapeutics Launch - Beacon Therapeutics
Jun 12, 2023 Find out more about us online at: beacontx.com. Related news: All news. Subretinal Gene Therapy Drug laru-zova (AGTC-501) for X-Linked Retinitis Pigmentosa โฆSee details»
Beacon Therapeutics Announces Positive 3-Month Data from โฆ
Dec 6, 2024 London, UK, Cambridge, MA, 6 December 2024 โ Beacon Therapeutics Holdings Limited (โBeacon Therapeuticsโ or โthe Companyโ), a leading ophthalmic gene therapy โฆSee details»